PALVELLA THERAPEUTICS, INC.

Profile

Company Names

PALVELLA THERAPEUTICS, INC.

Addresses

125 STRAFFORD AVENUE, STE 360, WAYNE, PA 19087

Phone Numbers

800-484-0260

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2015

State Incorporated:

DELAWARE

Total Amount Raised:

$63,935,957.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2022-12-16 
$9,704,497.00 
$37,704,498.00 
$28,000,001.00 
Equity 
3
2020-05-22 
$45,000,002.00 
$45,000,002.00 
$0.00 
Equity 
2
2019-03-29 
$4,791,954.00 
$5,000,000.00 
$208,046.00 
Equity 
1
2018-05-31 
$4,439,504.00 
$5,000,000.00 
$560,496.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ADITYA 
 
ASOKAN 
DIRECTOR
PALVELLA THERAPEUTICS, INC.
MICHAEL 
 
CHRISTOPHER 
DIRECTOR
PALVELLA THERAPEUTICS, INC.   |  LIFE SCIENCE PRIME, INC.   |  AUTOMATIONPRIME, INC.   |  CYBERPRIME, INC.
TODD 
 
DAVIS 
DIRECTOR
LIFELOCK, INC.   |  NURON BIOTECH, INC.   |  LIGAND PHARMACEUTICALS INC   |  TEARSCIENCE, INC.   |  PALVELLA THERAPEUTICS, INC.   |  KADENWOOD LLC   |  KADENWOOD, INC.   |  CAROMONT PARTNERS, LLC   |  SIGNING DAY SPORTS, INC.   |  QENTA INC.   |  RAD GOLF, INC.   |  BEETLEJUICE FIRST NATIONAL TOUR LLC   |  CHROMOCELL THERAPEUTICS CORP   |  PELTHOS THERAPEUTICS INC.
JOHN 
 
DOUX 
DIRECTOR
CEPTARIS THERAPEUTICS, INC   |  PALVELLA THERAPEUTICS, INC.   |  VALENZABIO, INC.
CORY 
 
FREEDLAND 
DIRECTOR
BIOCLIN THERAPEUTICS, INC.   |  NEUROGENE INC.   |  PALVELLA THERAPEUTICS, INC.   |  TENTARIX BIOTHERAPEUTICS, LP   |  ORSOBIO, INC.
KATHLEEN 
 
GOIN 
EXECUTIVE OFFICER
PALVELLA THERAPEUTICS, INC.
TIMOTHY 
 
HENKEL 
DIRECTOR
YAUPON THERAPEUTICS INC   |  CEPTARIS THERAPEUTICS, INC   |  PALVELLA THERAPEUTICS, INC.
ELAINE 
 
HERON 
DIRECTOR
ZEPHYRUS BIOSCIENCES, INC.   |  AMPLYX PHARMACEUTICALS, INC.   |  PALVELLA THERAPEUTICS, INC.   |  BLUEWHALE BIO, INC.
GEORGE 
 
JENKINS 
DIRECTOR
PHOTO HOLDINGS, INC.   |  SKINMEDICA INC   |  FLOWER ORTHOPEDICS CORP   |  PALVELLA THERAPEUTICS, INC.   |  CONVENTUS ORTHOPAEDICS INC
WESLEY 
H. 
KAUPINEN 
EXECUTIVE OFFICER, DIRECTOR
INTACT VASCULAR, INC.   |  PALVELLA THERAPEUTICS, INC.
JEFFREY 
 
MARTINI 
EXECUTIVE OFFICER
OSCOMP SYSTEMS INC.   |  HICOR TECHNOLOGIES, INC.   |  PALVELLA THERAPEUTICS, INC.
KATHLEEN 
 
MCGOWAN 
EXECUTIVE OFFICER
TOBIRA THERAPEUTICS, INC.   |  PALVELLA THERAPEUTICS, INC.
KATHLEEN 
A. 
MCGOWAN 
EXECUTIVE OFFICER
VAXINNATE CORP   |  PALVELLA THERAPEUTICS, INC.
SCOTT 
 
MORENSTEIN 
DIRECTOR
GEMIN X PHARMACEUTICALS INC   |  VALENCE ADVANTAGE LIFE SCIENCES FUND II, L.P.   |  CELATOR PHARMACEUTICALS INC   |  VELICEPT THERAPEUTICS, INC.   |  MOLECULAR TEMPLATES, INC.   |  ANTIOS THERAPEUTICS INC.   |  PRIMMUNE THERAPEUTICS, INC.   |  PALVELLA THERAPEUTICS, INC.
BRAHAM 
 
SHROOT, PH.D. 
EXECUTIVE OFFICER
PALVELLA THERAPEUTICS, INC.
DAVID 
 
TIERNEY 
DIRECTOR
BIOJECT MEDICAL TECHNOLOGIES INC   |  ICON BIOSCIENCE, INC.   |  PALVELLA THERAPEUTICS, INC.
TADD 
S 
WESSEL 
DIRECTOR
PALVELLA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-12-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-16 
2020-06-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-22 
2019-08-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-29 
2019-04-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-29 
2018-06-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#